Clinical trial
Thalidomide Plus Dexamethasone as Maintenance Therapy After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: a Multicenter Phase 3 Randomized Trial
NCT01296503 is registered in ClinicalTrials.gov with Grupo de Estudos Multicentricos em Onco-Hematologia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thalidomide Plus Dexamethasone as Maintenance Therapy After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: a Multicenter Phase 3 Randomized Trial
- Lead sponsor
- Grupo de Estudos Multicentricos em Onco-Hematologia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- December 31, 2010
- Enrollment
- 213 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.